Salvia BioElectronics discovers an innovative neurostimulation solution for the treatment of chronic migraine.
Migraine mostly found in one out of seven people among women causes disability. People affected with migraine suffer from episodes of throbbing, pulsating pain, migraine sometimes causes nausea, vomiting, and sensitivity to light, that can last anywhere from a few hours to a few days. Moreover, migraine has a negative impact on wellbeing and also affects the work, school, family and social lives.
With the availability of the newest generation drugs, very few people are able to procure the treatment, leaving many patients in medical need. Despite having the best medical treatments it is observed that people with migraine suffer from 15 or more headache days per month.
Since there are no devices commercially available for this disease, Neurostimulation would be the best effective treatment for patients. The solution designed with advanced features will benefit both physicians and patients.
U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation for implantable neurostimulation system to treat chronic migraine.
